Showing results (991-1000 of 1,984) with videos related to

Sort By:
Pageof 199
The Lancet. Neurology|April 17, 2024
MAPT H2 haplotype and risk of Pick's disease in the Pick's disease International Consortium: a genetic association studyRebecca R Valentino, William J Scotton, Shanu F Roemer, et al.
The Lancet. Neurology|April 17, 2024
Safety and efficacy of losmapimod in facioscapulohumeral muscular dystrophy (ReDUX4): a randomised, double-blind, placebo-controlled phase 2b trialRabi Tawil, Kathryn R Wagner, Johanna I Hamel, et al.
The Lancet. Neurology|April 21, 2024
Medical management and surgery versus medical management alone for symptomatic cerebral cavernous malformation (CARE): a feasibility study and randomised, open, pragmatic, pilot phase trial
The Lancet. Neurology|April 27, 2026
Safety and efficacy of the anti-α-synuclein monoclonal antibody amlenetug for the treatment of patients with multiple system atrophy (AMULET): a phase 2, randomised, double-blind, multicentre trialLotte Kjærsgaard, Jonas Wiedemann, Wolfgang Singer, et al.
The Lancet. Neurology|April 20, 2026
Safety and efficacy of individualised exercise and NAD+ precursor supplementation in patients with Friedreich's ataxia in the USA: a single-centre, 2 × 2 factorial, randomised controlled trialKimberly Y Lin, Anna Bucha, Kara McSweeney, et al.
The Lancet. Neurology|April 20, 2026
Cognitive resilience in ageing: determinants and interventionsAlice Powell, Karina Chan, Claire E Shepherd, et al.
The Lancet. Neurology|May 13, 2026
Safety, tolerability, and efficacy of acetazolamide in idiopathic normal pressure hydrocephalus (DRAIN) in Sweden: a randomised, double-blind, placebo-controlled, phase 2 trialJohan Virhammar, Oskar Fasth, Maria Ekblom, et al.
The Lancet. Neurology|July 22, 2019
An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and modelsJosep Dalmau, Thais Armangué, Jesús Planagumà, et al.
The Lancet. Neurology|June 21, 2020
Medical management with interventional therapy versus medical management alone for unruptured brain arteriovenous malformations (ARUBA): final follow-up of a multicentre, non-blinded, randomised controlled trialJay P Mohr, Jessica R Overbey, Andreas Hartmann, et al.
The Lancet. Neurology|June 17, 2026
Spontaneous spinal CSF leaks: a rare variant exome sequencing study and functional analysisCassie A Parks, Mukti Singh, Elizabeth Wohler, et al.
Pageof 199